Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of providing additional funding to help decrease mortality rates for those diagnosed with pancreatic cancer.

We have allocated more than £8 billion from 2022/23 to 2024/25, in addition to the £2 billion Elective Recovery Fund and £700 million Targeted Investment Fund already made available in 2021/2022 to increase elective activity, including in cancer services. In addition, the autumn statement provided an additional £3.3 billion in 2023/24 and 2024/25 to increase capacity in the National Health Service.